P-277 Real-world efficacy, safety, and impact of the GIPI score of nivolumab in advanced esophageal squamous cell carcinoma (ESCC) refractory or intolerant to prior chemotherapy in European population: The EPIC trial

  1. Lago, N. Martínez 3
  2. Castiñeiras, A. Cousillas 1
  3. Villarroel, P. Gonzalez 6
  4. Fernández-Montes, A. 2
  5. Maseda, A. Carral 5
  6. Rivas, M. Costa 4
  7. Reboredo-Lopez, M. 1
  1. 1 Complexo Univ Hosp Pontevedra, Pontevedra, Spain
  2. 2 Complexo Univ Hosp Ourense, Orense, Spain
  3. 3 Complejo Hosp Univ Ferrol, El Ferrol, Spain
  4. 4 Hosp POVISA, Vigo, Spain
  5. 5 Hosp Univ Lucas Augusti, Lugo, Spain
  6. 6 Hosp Alvaro Cunqueiro, Vigo, Spain
Mostrar afiliacións +
Actas:
25th World Congress on Gastrointestinal Cancer

ISSN: 0923-7534,  1569-8041

Ano de publicación: 2023

Volume: 34

Páxinas: S113-S114

Tipo: Achega congreso

DOI: 10.1016/J.ANNONC.2023.04.333 GOOGLE SCHOLAR lock_openAcceso aberto editor